Effect of pregnane X receptor and cytochrome P450 oxidoreductase gene polymorphisms on trough concentrations of rivaroxaban and edoxaban in patients with nonvalvular atrial fibrillation.

Nakagawa, Junichi; Kinjo, Takahiko; Aiuchi, Naoya; Ueno, Kayo; Tomita, Hirofumi; Niioka, Takenori

Nakagawa, Junichi; Kinjo, Takahiko; Aiuchi, Naoya; Ueno, Kayo; Tomita, Hirofumi; Niioka, Takenori.

Afiliação

Nakagawa J; Department of Pharmacy, Hirosaki University Hospital, 53 Hon-cho, Hirosaki, Aomori, 036-8563, Japan.
Kinjo T; Department of Cardiology, Hirosaki University Graduate School of Medicine, Aomori, Japan.
Aiuchi N; Department of Pharmacy, Hirosaki University Hospital, 53 Hon-cho, Hirosaki, Aomori, 036-8563, Japan.
Ueno K; Department of Pharmacy, Hirosaki University Hospital, 53 Hon-cho, Hirosaki, Aomori, 036-8563, Japan.
Tomita H; Department of Cardiology, Hirosaki University Graduate School of Medicine, Aomori, Japan.
Niioka T; Department of Pharmacy, Hirosaki University Hospital, 53 Hon-cho, Hirosaki, Aomori, 036-8563, Japan. t-niioka@hirosaki-u.ac.jp.

Eur J Clin Pharmacol ; 79(5): 703-705, 2023 05.

Article em En | MEDLINE | ID: mdl-36951964

Assuntos

Fibrilação Atrial; Acidente Vascular Cerebral; Humanos; Rivaroxabana/uso terapêutico; Fibrilação Atrial/tratamento farmacológico; Fibrilação Atrial/genética; Receptor de Pregnano X/genética; Sistema Enzimático do Citocromo P-450; Anticoagulantes/uso terapêutico; Inibidores do Fator Xa/uso terapêutico

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fibrilação Atrial / Acidente Vascular Cerebral Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google